- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on EGFR Mutant Advanced Non-small Cell Lung Cancer
Total 7000 results
-
Institut Claudius RegaudMerck KGaA, Darmstadt, GermanyCompletedLocally Advanced Non Small Cell Lung Cancer (NSCLC)France
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
Swiss Group for Clinical Cancer ResearchCompletedLung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung CancerSwitzerland
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
Case Comprehensive Cancer CenterTerminatedAdvanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)United States
-
Ass. Prof. Jan NymanTerminatedNon Small Cell Lung Cancer | Locally Advanced DiseaseSweden
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
AbbVieActive, not recruitingAdvanced Solid Tumors Cancer | Non Small Cell Lung Cancer (NSCLC)United States, Australia, France, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
Tianjin Medical University Cancer Institute and...RecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung Cancer | Bevacizumab | Tyrosine Kinase InhibitorChina
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingAdvance Non-small Cell Lung CancerSpain, Italy, Greece
-
RaND BiosciencesNot yet recruitingAdvanced Biliary Tract Cancer | Advanced Non-small-cell Lung Cancer
-
Soroka University Medical CenterUnknownLocally Advanced Inoperable Non-small-lung CancerIsrael
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingAdvanced or Metastatic Non-small Cell LungChina
-
Chao HuangUniversity of Kansas Medical CenterActive, not recruitingAdvanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC)United States
-
Jeffrey ClarkeNovartis Pharmaceuticals; NantCell, Inc.CompletedAdvanced Solid Tumors, Non-small Cell Lung CancerUnited States
-
PfizerCompletedNon Small Cell Lung Cancer | Advanced Solid TumorsUnited States
-
Samsung Medical CenterNot yet recruitingMetastatic Lung Non-Small Cell Carcinoma | EGFR T790MKorea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung CancerUnited States
-
Anbogen Therapeutics, Inc.RecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | HER2 MutationsTaiwan
-
AkesoRecruitingAdvanced Non-small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
Kobe Minimally Invasive Cancer CenterMerck Sharp & Dohme LLCNot yet recruitingLocally Advanced Non-small Cell Lung Cancer
-
CStone PharmaceuticalsPfizerActive, not recruitingAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Sun Yat-sen UniversityWithdrawnEfficacy and Safety | Locally Advanced Non-small Cell Lung CancerChina
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedAdvanced Stage Non-small Cell Lung CancerUnited States
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
Istituto Oncologico Veneto IRCCSMinistry of Health, ItalyCompletedAdvanced Non Small Cell Lung CancerItaly
-
Alexander ChiNot yet recruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage IIChina
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | Metastatic Head and Neck... and other conditionsUnited States
-
Stanford UniversityAstraZenecaRecruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited States
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States
-
Fujian Cancer HospitalEnrolling by invitation
-
Fondazione Ricerca TraslazionaleUnknownNon Small Cell Lung Cancer | Metastatic Cancer | Advanced CancerItaly
-
PfizerActive, not recruitingNon-small-cell Lung Cancer | Advanced MalignanciesChina, Korea, Republic of, Taiwan, Japan, Russian Federation, Ukraine
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
NYU Langone HealthRecruitingAdvanced Non-small Cell Lung Cancer With KRAS G12C MutationUnited States
-
University of OxfordCancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaboratorsCompletedLocally Advanced Non-Small Cell Lung CancerUnited Kingdom
-
National Cancer Institute (NCI)Not yet recruitingStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
Mirati Therapeutics Inc.RecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Colo-rectal CancerUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | TNBC - Triple-Negative Breast Cancer | NSCLC Stage IV Without EGFR/ALK MutationUnited States, Canada
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States